Clinical trial
Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After…
NCT00334490 · Unity Health Toronto, Other · Completed
Key facts
| NCT number | NCT00334490 |
|---|---|
| Title | Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery? |
| Official title | A Phase II, Double Blind Randomized Controlled Trial to Determine the Safety and Efficacy of 12.5mg of Oral Sildenafil (Viagra) Compared to Placebo to Decrease Pulmonary Hypertension in Cardiac Patients After Cardiopulmonary Bypass |
| Lead sponsor | Unity Health Toronto, Other |
| Collaborators | University of Toronto |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | Sildenafil, Placebo |
| Enrollment | 40 |
| Start date | Mar 1, 2005 |
| Primary completion | Apr 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Jun 7, 2006 |
| Last update posted | Jul 31, 2015 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: